Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Efficacy and safety of Tislelizumab combined with Bevacizumab and chemotherapy in patients with persistent, recurrent or metastatic cervical cancer.

carcinoma
aptt
growth factors
squamous cell carcinoma
recurrent cervical cancer
  • 0 views
  • 21 Jul, 2022
  • 1 location
Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix (NIVIX)

The most effective strategy for managing distantly metastatic invasive carcinomas of the cervix is not defined. Based on the success of niraparib in breast and ovarian cancer trials and the concern for toxicities and comorbidities limiting the compliance of concurrent cisplatin for cervical cancer, this study is a phase I/II …

  • 0 views
  • 10 May, 2022
  • 1 location
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

This is a phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer that had failed first line of therapy. The

neutrophil count
aptt
growth factors
pembrolizumab
measurable disease
  • 0 views
  • 08 Aug, 2022
  • 2 locations
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

The investigators propose to evaluate the efficacy of the combination of standard chemotherapy with bevacizumab with Pembrolizumab in women with recurrent, persistent, or metastatic cervical

carcinoma
aptt
pembrolizumab
cancer
metastasis
  • 102 views
  • 22 Mar, 2022
  • 1 location
Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer (TIL)

A study that aimed to assess the safety and anti-tumor activity of C-TIL052A cell therapy in subjects with persistent, recurrent and/or metastatic cervical cancer.

metastatic cervical cancer
  • 0 views
  • 11 Aug, 2022
  • 2 locations
TILs for Treatment of Metastatic or Recurrent Cervical Cancer

after a non-myeloablative (NMA) lymphodepletion preparative regimen for the treatment of patients with recurrent, metastatic cervical carcinoma.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

This study is a prospective, multicenter, phase II clinical trial to evaluate the efficacy and safety of albumin-bound paclitaxel plus bevacizumab for platinum-resistant recurrent epithelial ovarian cancer. Patients with platinum-resistant recurrent ovarian cancer who meet the inclusion criteria, and don't meet any of the exclusion criteria, are enrolled in the …

  • 0 views
  • 27 Apr, 2022
  • 1 location
Donafenib for Recurrent Cervical Cancer

This study is to evaluate the safety and tolerability of Donafenib combined with paclitaxel and platinum ± programmed death 1 monoclonal antibody (PD-1 antibody) in patients with recurrent cervical cancer.

paclitaxel
carcinoma
measurable disease
creatinine clearance rate
cancer
  • 0 views
  • 19 Apr, 2022
  • 1 location
Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

To explore the efficacy and tolerance of adding toripalimab simultaneously and subsequently to concurrent platinum-based chemoradiotherapy in patients with locally advanced cervical cancer.

chemoradiotherapy
blood urea nitrogen
  • 0 views
  • 28 Oct, 2021
  • 1 location
A Study of XmAb20717 in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of XmAb20717 in patients with selected advanced gynecologic and genitourinary malignancies.

cancer chemotherapy
carcinoma
cervical carcinoma
measurable disease
cancer
  • 0 views
  • 09 Aug, 2022
  • 2 locations